Dysregulation of the mTOR pathway is implicated in a spectrum of pathophysiological conditions, ranging from premature aging and neurodegenerative diseases like Alzheimer’s to metabolic disorders such as diabetes and obesity, as well as cancer [1,2,3]. The gene discussed is MTOR; the disease is obesity due to melanocortin 4 receptor deficiency.